At ICV Cambridge 2016, we will bring visibility to sustainable companies and organizations front and center to an investment community by virtue and wealth that can advance corporate responsibility, capitalize businesses at significant levels, and influence systemic change in the world.

ICV Cambridge 2016 will convene the management of companies that are shaping the future of traditional industries, the next generation and investment officers of single family offices, top industry-focused institutional investors and distinguished academics working at the forefront of their field.

Investor registration is complimentary, but highly vetted. This event will not be sponsored. Service providers may not attend.
 
 

 

Family Office Roundtable

Members of single family offices will speak openly on a wide range of topics such as sourcing deal flow, direct investing, allocating to professional managers, and family governance.

  • Andrew Fisch, Managing Director of Investcorp, a global provider and manager of alternative investment products, serving high-net-worth private and institutional clients. Andrew joined Investcorp in 2015 as the Portfolio Manager of the SSARIS portfolio. Previously, Andrew was the Chief Investment Officer of the Hedge Fund of Funds Group at SSARIS Advisors, LLC and a member of the Executive Management Team. He was also a member of the Hedge Fund of Funds Investment Committee. Prior to joining SSARIS, he was a founding partner at Aurum Capital Management where he managed the Aurum Venture Fund (Venture Capital) and developed various hedge fund of funds products.
  • Kevin McGovern, Chairman and CEO of McGovern Capital and The Water Initiative®, which co-creates customized and sustainable drinking water solutions through innovative partnerships with municipalities, business and local microentrepreneurs in developing and developed countries. Through McGovern Capital, he has founded over fifteen companies, six of which have become world/category leaders, has been lead negotiator/principal in over twenty (20) global joint ventures. McGovern Capital serves as an investment, strategy and licensing participant and advisor to global businesses. McGovern was a founder of SoBe Beverages, the fastest growing beverage company ever in the US (sold to Pepsi), and McGovern Capital was one of three owners of KX Industries, L.P., the largest manufacturer and worldwide source of carbon water purification filters, having invented and supplied PUR to P&G, the first end-of-tap filter to Brita, and the first refrigerator water filter to Electrolux. He also created the program, supervised and negotiated all licensing of Tristrata’s alpha hydroxy acid (AHA) patents, which technology was incorporated in approximately 40% of all global skin care products, and is sold in approximately 88 countries. He serves/served on many public and private boards including The Sports Authority (Exec. Committee – NYSE).
  • Nick Davis Raynes began his business career at a young age working an apprenticeship alongside his grandfather, Marvin Davis, a wildcatter, who later owned 20 Century Fox, Pebble Beach Golf Course, The Beverly Hills Hotel, The Aspen Mountain, Little Nell Hotel, and built the Fox Plaza in Los Angeles, amongst many other private and public sector deals. Nick has since invested and raised capital for real estate, technology, energy, and alternative energy deals and currently works with a private equity firm based in San Francisco that invests in real assets globally. Nick is passionate about start-up companies and sits on various advisory boards. He is active with charitable causes including his grandmother Barbara Davis’ Children’s Diabetes Foundation and Carousel of Hope Ball that raises funds for juvenile diabetes.
    • Michael Sury is an Adjunct Professor of Financial Economics, University of California, and Chairman of INDORUS Holdings, a single family office that was formed after the sale of the investment firm he founded and ran from 2000-2009—a nationally top ranked, multi-billion dollar investment adviser to wealthy families and institutional investors. Mr. Sury is an internationally recognized expert in financial economics and award-winning professor, having taught undergraduate and MBA courses, including at the University of California, Santa Clara University, DePaul University and San Diego State University. His pioneering work in the areas of portfolio optimization, asset allocation, and risk management has been applied by sovereign entities, institutional investors, and family offices worldwide. He began his career in finance at Goldman Sachs in the early ’90s, first recruited as a professional trader in the firm’s Equities Division, then as a Vice President in the Investment Management Division. Prior to graduate school, Mr. Sury had worked in technology consulting and then as a criminal investigator, assisting in the development of one of the nation’s first task forces dedicated to high tech and economic crime investigations. His special interests are as follows: Energy Investment, Global Macroeconomic Policy, Strategic Asset Allocation, Tactical Trading, Global Portfolio Optimization, Alpha-Beta Identification & Separation, Manager Selection and Performance Measurement, and Special Situations.

 

Investment Outlook: Healthcare I

Investors with a focus on innovation and research to implement an impact investment within health and life sciences share their industry insights and investment outlook.

  • Randy Cohen, PhD, is a Senior Lecturer at Harvard University, a Visiting Associate Professor of Finance at the MIT Sloan School, and a Partner at Exsight Capital, a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions.. Previously, Dr. Cohen taught at the Harvard Business School as Associate Professor of Finance and co-founded Vision Capital Advisors, LLC. Before joining Harvard, he worked as an actuarial management consultant specializing in pension plan asset/liability analysis. Dr. Cohen lectures worldwide on investment management and valuation of “hard to value” assets, has published working papers on the subjects of Alternative Investment Management, Asset Pricing, and Finance, and is a member of the American Finance Association and the European Finance Association.
  • Jeffrey Moore, DPhil, President of MP Healthcare Venture Management, a venture capital firm that invests in innovative research-driven companies in the areas of biotechnology, therapeutics and vaccines. Founded in 2006, MPH is a subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC). By working with MPH, promising companies can gain access to the funding and industry expertise needed to bring state-of-the-art products to market.
  • Kuldeep Neote, PhD, Senior Director, New Ventures of Johnson & Johnson Innovation, the venture capital subsidiary of Johnson & Johnson, which is comprised of experts and leaders in the health care and technology venture communities who identify early market indicators, health care trends, and strategic investment opportunities. Unlike traditional venture capital firms, Johnson & Johnson Innovation determines the success of an investment’s performance not only in financial returns, but also in the viability of providing strategic growth options for Johnson & Johnson.
    • David Shrier, Managing Director of MIT Connection Science, which seeks to revolutionize technology-mediated human networks through analysis, prediction, data-driven design, and evaluation. David is also the New Ventures Officer of MIT, where he helps the innovators themselves to innovate, by driving a concurrent portfolio of new initiatives for MIT alongside senior faculty and Institute leadership.

 

Investment Outlook: Healthcare II

Investors with a focus on innovation and research to implement an impact investment within health and life sciences share their industry insights and investment outlook.

  • Neta Batscha, Analyst of RA Capital Management, a healthcare crossover fund manager based in Boston that invests in development-stage private and public drug, medical device, and diagnostic companies.
  • Bihua Chen, CEO and Portfolio Manager of Cormorant Asset Management, a long/short public equity fund in healthcare, as well as a private equity/venture capital fund; $900 million AUM. Prior to founding Cormorant, Ms. Chen managed a separately managed account focused on the healthcare sector as a sub-adviser to a large, multi-strategy hedge fund based in New York. During Ms. Chen’s time managing the account (from 2005 through 2010) the account grew from $75 million in assets to $800 million in assets. She obtained an MBA from the Wharton School of Business in 1998 and graduated with a Master of Science, Molecular Biology, from the Graduate School of Biomedical Science at Cornell Medical College in 1994. Ms. Chen also holds a Bachelor of Science degree in Genetics and Genetic Engineering from Fudan University, Shanghai, China, which she received in 1990.
  • Les Funtleyder is an Adjunct Professor of Public Health at Columbia. He is also Portfolio Manager of E Squared Asset Management, an accomplished family office targeting emerging growth companies with potentially disruptive technologies or services.
  • Sergei Petukhov, PhD, is a Partner of Enso Ventures, a private investment company that specializes in making selective investments in Europe and the USA. The company focuses on two distinct fields: materials-technology and biotechnology. The flexibility of the company’s structure and its hands-on approach means it can invest in a wide array of opportunities. The family office harnesses its industry expertise, leadership and capital in order to commercially develop and accelerate technologies in start-up companies. Dr. Sergei Petukhov is a Partner of Enso Ventures. Dr. Petukhov was a Managing Director at CLS Capital, he worked at RUSNANO investment fund and was an advisor at Kaye Scholer LLP for number of US pharmaceutical companies. Dr. Petukhov led Enso biotechnology investments and took several board observer positions at Enso portfolio companies including Seres Therapeutics, Galera Therapeutics and Cellectar Biosciences. Dr. Petukhov worked and studied at The Rockefeller University, The University of Edinburgh, The University of Cambridge and Moscow 1st Medical Academy.
  • Christian Suojanen is a Partner at Valor Management and Co-Chairman of TTS Ltd and Partner, Head of Life Sciences at TTS Global Initiative, through which he serves as a strategic adviser in the biotech sector, to funds, CEOs, companies, TTOs, and governments. With a focus on Europe, North America and the BRIC countries, his specializations are in licensing, strategic business development, fund-raising, and capital formation, selectively accepting a small number of mandates and supporting these closely, often in an acting or virtual management role focused on finance and business development. As a turn-around engagement as Executive Board member and Secretary General, he revived Europe’s largest biotech association and rebuilt membership, developed strong international relations with relevant organizations, increased revenues, launched new member services and Public Affairs initiatives at the European level, re-branded and successfully relaunched a fading international scientific congress, and negotiated the creation of an official society journal with a leading publisher. He also serves on the Finance Committee of the Think Tank EPPOSI (European Platform for Patients Organizations, Science & Industry), and on the Editorial Board of New Biotechnology (Elsevier).

 

Meat the Future? Fulfilling demand for 9 Billion People by 2050

Produced by Foodcrunch.com, a non-profit initiative focused on building a robust eco-system of information and people to help entrepreneurs start and grow their food-system businesses.

On a shrinking planet, never before has the future of food been in such peril. Already gobbling up one-third of total land mass and over 75% of available freshwater – many see modern agriculture as a malthusian catastrophe set to systematically exhaust resources, and thus us. But, others see differently. By developing creative models focused on ingenuity and resilience, some innovators have taken the proverbial bull-by-the-horns to disrupt the single largest sector of US agriculture through redefining the narrative of future meat. Teeming with environmental, animal welfare, and human health concerns, the production of food animals now tops 60B around the globe. Expensive in both materialized costs and externalities, concerns grow if the world can afford the production of more meat as we know it?! With global population set to grow by 40% in less than two generations, and evolving consumer demand desiring a diet of more animal protein – we need better solutions to maintain stability. Running the gamut of short & long horizon potential, diverse asset classes and risk profiles – join this engaging panel of food system experts in exploring the opportunities of the future of meat, agriculture and food security.

  • David Beutel, Aquaculture Coordinator of the The Rhode Island Coastal Resources Management Council (CRMC), a management agency with regulatory functions. Its primary responsibility is for the preservation, protection, development and where possible the restoration of the coastal areas of the state via the issuance of permits for work with the coastal zone of the state.
  • Michael Leviton is a seven-time James Beard Foundation Award nominee and recipient of national awards from Food & Wine, Bon Appétit, Gourmet and Saveur. He is the former owner of Lumière, one of the best restaurants in the Boston area.
  • Aaron Niederhelman, Principal & Co-Founder of the EAF Agrarian Fund, a real-asset investment fund designing profitable farming enterprises to meet growing the market demand for better quality food with regional provenance. Capitalizing on immediate market demand, the EAF utilizes regional production efficiency to create strong investor returns through cash-flow from a consistent supply of premium crops, and on-going improvement to land and soil quality. He is an Eisenhower Fellow, a premier global network of leaders from all sectors working to better the world, from which his research into nutrient security, food-system reform and water access throughout Europe & the Middle-East has been instrumental in promotion of food for its human and planetary OneHealth.
  • Lisa Sebesta, Managing Partner of Fresh Source Capital , a Cambridge, MA based investment firm focused on sustainable food and agriculture, with a mission to invest in companies that are rebuilding local, regional food systems.
    • Greg Shell, Managing Director of Bain Capital, one of the world’s leading private multi-asset alternative investment firms with more than $75 billion in assets under management that creates lasting impact for our investors, teams, businesses and the communities in which we live. Greg joined Bain Capital Double Impact as a managing director in 2016. Prior to joining, Mr. Shell served as a Lead Portfolio Manager of a concentrated Global Equity product at GMO. Previously, Mr. Shell was a Senior Equity Analyst at Columbia Management Group and a Consultant at Bain & Company in its Strategy and Private Equity practice areas.

 

Life, Animated: Using Artificial Intelligence to Address Autism

IMAGINE being trapped inside a Disney movie and having to learn about life, language, and emotion mostly from animated characters dancing across a screen of color. A fantasy? A nightmare? Actually, it’s the real-life story of Owen Suskind, who is the son of the Pulitzer Prize–winning journalist Ron Suskind and his irrepressible wife, Cornelia. Owen is also a boy with autism, which now affects an astonishing one in every one hundred children. While America’s two million autistic people are just as diverse as the wider population, many possess a subtle weave of gifts and challenges that, year by year, are revealing underlying—and often unrecognized—capacities of the human mind. What the journey of this boy and his family powerfully reveals: how, in darkness, we literally need stories to survive. Here’s how this survival story begins. Just shy of his third birthday, a seemingly typical, chatty child became mute. He suddenly didn’t sleep or eat, and cried inconsolably. His only solace: the Disney animated movies he loved before the autism struck. But they had changed, too—they’d become gibberish, because the boy’s ability to understand speech had also vanished. So he memorized them, dozens of them, based on sound alone. What follows are a series of startling breakthroughs, as, for years, the family began to communicate with their lost son in movie dialogue. Recite one line, he’d look you in the eye and recite the next. But was he understanding? His parents dove down “Alice in Wonderland’s rabbit hole,” as one autism specialist said, “to rescue a child.” But it soon became unclear who rescued whom, as they and their older son, Walt, literally had to become animated characters, forced to contemplate the deepest meanings of iconic myths—the stories people have long told themselves to make their way in the world—just to keep up. Because a startling truth began to take shape across a frenetic, harrowing, raucous decade: in the land of imagination, a “left behind” boy, murmuring under his breath, was king. The creator of worlds. In fact, their young son had invented a language to express love and loss, the bonds between brothers, the nature of beauty, and the true meaning of the words “happily ever after.” At its core, this brilliantly crafted narrative—written by the father, but shaped by his wife and children—isn’t about autism or Disney, though you’ll never view either one quite the same, again. It’s the story of a family’s resilience when their world is turned upside down. It’s about perseverance and hope. A child disappeared into confusion, frustration, and silence. But deep inside his dark cave of isolation, he and his family began to dig for diamonds, working year by year, trial by trial, on a most improbable project: to find a way each of us can learn to animate our lives. And live our most fervent dreams, whatever unexpected shape they take.

Life Animated Ron Suskind
  • Ron Suskind is a Pulitzer Prize-winning journalist and author who has written some of America’s most important works of nonfiction, framing national debates while exploring the complexities of human experience. Ron’s latest work, Life, Animated, A Story of Sidekicks, Heroes and Autism, chronicles his family’s twenty year struggle with their youngest son’s autism. The book, a journey of the heart, much in the style of his first book, A Hope in the Unseen, takes readers to the core of the most fundamental human issues – love, faith, friendship, brotherhood, what parents can offer their children, and how, in moments of darkness, we literally need stories to survive. His previous works include the New York Times bestsellers, Confidence Men (Sept. 2011) about the fall of the U.S. economy and the presidency of Barack Obama; The Way of the World (August, 2008), about the forces fighting the global “hearts and minds” struggle at a time when awesomely destructive weapons are available to the common man; The One Percent Doctrine (June, 2006), a signature work on how the U.S. government frantically improvised to fight a new kind of war after 9/11; The Price of Loyalty, George W. Bush, the White House and the Education of Paul O’Neill (Jan, 2004), a sweeping tour of the inner workings of the American government in the modern era; and A Hope in the Unseen, An American Odyssey from the Inner City to the Ivy League (1998) a critically-acclaimed bestseller that has redefined national debates on race, class and achievement. In addition to his books, he often appears on network television and has been a contributor for The New York Times Magazine and Esquire. Mr. Suskind was the Wall Street Journal’s senior national affairs reporter from 1993 until his departure in 2000, and won the 1995 Pulitzer Prize for Feature Writing. He currently lives in Cambridge, Mass., with his wife, Cornelia Kennedy, and is a Lecturer at Harvard Law School.
A Private Tour of the JFK Library & Museum by Stephen Kennedy Smith

President Kennedy inspired a generation to accept responsibility for its government, and its world, by taking political and social action. As president, he fought to ensure equal rights and opportunities for all Americans. He encouraged Americans to lift up those less fortunate than themselves, both at home and abroad. He challenged the nation to reach for the impossible and land a man on the moon before the end of the decade. He set new directions for international diplomacy, seeking better relations with Latin America and newly independent nations. He reduced the threat of nuclear war by opening the lines of communication with Moscow and offering to help “make the world safe for diversity.”

John F. Kennedy’s legacy is a vision of political action and public service based on courage, service, inclusion, and innovation.

JFK Centennial at the JFK Library

In a private tour of the John F. Kennedy Presidential Library & Museum, Stephen Kennedy Smith will give a fresh take on the relevance of his uncle’s words today, JFK’s life and presidency, and his compelling vision for America.

  • Stephen Kennedy Smith is a principal at Park Agency – Joseph P. Kennedy Enterprises, the Kennedy family office, and an investor and entrepreneur. He has served as a director or advisor to several companies, including Gridline Communication Holdings, Pear Therapeutics, Owl Biomedical, and LocoMobi. His current investment and business focus is scaling innovative healthcare, and neuroscience companies. Stephen is a board member of the John F. Kennedy Library and The Joseph P. Kennedy Foundation. He also serves on the advisory board at INCAE Business School. He is cofounder and vice president of the World Leadership Alliance, an organization of business and political leaders that promotes, democracy, international understanding and trade. Stephen is currently a lecturer at the Sloan school of Management in the visionary investing program, as well as a fellow at the Connection Science Group at MIT. He holds an M.A. from Harvard University, a J.D. from Columbia University, and an M.A. Ed. from Harvard’s School for Education. He has served on the staff of the Senate Judiciary and Foreign Relations Committees.

 

An Evening of Great Literature and Music

Esteemed guests will visit the Ernest Hemingway Collection, the generous gift of Mary Hemingway, Ernest Hemingway’s widow, to the John F. Kennedy Presidential Library and Museum, and to Hemingway scholars and readers around the world. The collection spans Hemingway’s entire career, and contains ninety percent of existing Hemingway manuscript materials, making the Kennedy Library the world’s principal center for research on the life and work of this author.

 

 
The History of the Boston Pops

It all began in 1885, thanks to the vision of Civil War veteran Henry Lee Higginson. Fours years earlier, in 1881, he founded the Boston Symphony Orchestra, calling its establishment “the dream of my life.” From the start he intended to present, in the warmer months, concerts of light classics and the popular music of the day. From a practical perspective, Higginson realized that these “lighter” performances would provide year-round employment for his musicians. The “Promenade Concerts,” as they were originally called, were soon informally known as “Popular Concerts,” which eventually became shortened to “Pops,” the name officially adopted in 1900. The following year the orchestra performed for the first time in its new home, Symphony Hall. Not only is this performance space acoustically outstanding, it was also designed, at Higginson’s insistence, so that the rows of seats for Boston Symphony concerts could be replaced by tables and chairs for Pops concerts. Read more.
 

“Music in the soul can be heard by the universe.”

 – Lao Tzu

 
 
Philanthropy

Childhood Cancer Kids is a 501(c)(3) non-profit organization, seeks to increase childhood cancer awareness and to provide resources to and elevate the spirits of children with cancer.

Childhood Cancer Kids
  • Sierra Preveza, Founder of Childhood Cancer Kids, is a survivor of kidney cancer who was diagnosed at the age of 6. A Wilms’ tumor stage 2, the size of a grapefruit, grew rapidly inside of Sierra. She was very fortunate; she underwent surgery at Boston Children’s Hospital and the tumor was removed. A year after her experience and strong recovery, Sierra decided she wanted to give to other kids with cancer and founded Childhood Cancer Kids. She has three missions: to fundraise for places that support childhood cancer, to provide yoga relaxation techniques for kids going through and recovering from cancer, and to raise the level of Childhood Cancer Awareness Month in September. The Today Show named Sierra the Kindest Kid in America and she is the Sprout Network’s Chief Kindness Officer.

 

Writers Without Margins is dedicated to the fusion of art and advocacy, and takes literature beyond conventional spaces. Its mission is to connect the rich literary and academic resources of our city, its authors, and artists, with its unheard or underserved populations through free literature and writing programs which empower, educate and enable people marginalized, stigmatized, or isolated by the challenges of mental illness, addiction recovery, disability, trauma, sickness, injury or poverty.

Writers Without Margins

Writers Without Margins aims to amplify the voices of participants through collaborative workshops, readings, literary journals, publications and exhibits that showcase their work, encouraging personal reflection and re-vision by both author and audience, while sharing their stories with the world.

 

 
 
Venues

Loeb House at Harvard University
17 Quincy Street
Cambridge, MA 02138
(617) 495-5728

John F. Kennedy Presidential Library and Museum
Columbia Point
Boston, MA 02125
(617) 514-1600

 
 
Agenda
 
08:00 AM BREAKFAST: LOEB HOUSE at HARVARD UNIVERSITY    
START END Breakout Rooms:
"Crimson"

"Ivy"
 
8:20 9:00 INVESTMENT OUTLOOK: FOOD SYSTEMS  
9:05 9:25 COMPANY PRESENTATION COMPANY PRESENTATION
9:30 9:50 COMPANY PRESENTATION COMPANY PRESENTATION
BREAK  
10:00 10:40 INVESTMENT OUTLOOK: HEALTHCARE   
10:45 11:05 COMPANY PRESENTATION COMPANY PRESENTATION
11:10 11:30 COMPANY PRESENTATION COMPANY PRESENTATION
11:35 12:05 COMPANY PRESENTATION COMPANY PRESENTATION
12:10 12:40 INVESTMENT OUTLOOK: HEALTHCARE II  
LUNCH  
1:50 2:05 CHILDHOOD CANCER KIDS  
2:10 2:40 LIFE, ANIMATED  
2:45 3:05 COMPANY PRESENTATION COMPANY PRESENTATION
3:10 3:30 COMPANY PRESENTATION COMPANY PRESENTATION
3:35 4:15 FAMILY OFFICE ROUNDTABLE  
4:30 5:15 PM SHUTTLE: JOHN F. KENNEDY PRESIDENTIAL LIBRARY & MUSEUM
5:15 6:00 PM ERNEST HEMINGWAY EXHIBIT
5:15 6:00 PM MEMBERS OF THE BOSTON POPS ORCHESTRA
6:00 9:00 PM NETWORKING & DINNER RECEPTION
9:30 10:00 PM SHUTTLE: HARVARD UNIVERSITY